ATE189385T1 - Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems - Google Patents
Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystemsInfo
- Publication number
- ATE189385T1 ATE189385T1 AT97919465T AT97919465T ATE189385T1 AT E189385 T1 ATE189385 T1 AT E189385T1 AT 97919465 T AT97919465 T AT 97919465T AT 97919465 T AT97919465 T AT 97919465T AT E189385 T1 ATE189385 T1 AT E189385T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- diseases
- nervous system
- benzonaphtalene
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9604359A FR2747041B1 (fr) | 1996-04-05 | 1996-04-05 | Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies |
| PCT/FR1997/000590 WO1997037648A1 (fr) | 1996-04-05 | 1997-04-02 | Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des maladies du systeme nerveux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE189385T1 true ATE189385T1 (de) | 2000-02-15 |
Family
ID=9490993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97919465T ATE189385T1 (de) | 1996-04-05 | 1997-04-02 | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6043280A (de) |
| EP (1) | EP0900078B1 (de) |
| JP (1) | JP2000512619A (de) |
| KR (1) | KR20000005179A (de) |
| CN (1) | CN1221341A (de) |
| AT (1) | ATE189385T1 (de) |
| AU (1) | AU717704B2 (de) |
| BR (1) | BR9708511A (de) |
| CA (1) | CA2250755A1 (de) |
| CZ (1) | CZ317698A3 (de) |
| DE (1) | DE69701258T2 (de) |
| ES (1) | ES2144857T3 (de) |
| FR (1) | FR2747041B1 (de) |
| GR (1) | GR3033061T3 (de) |
| HU (1) | HUP9902167A3 (de) |
| NO (1) | NO984651L (de) |
| NZ (1) | NZ332158A (de) |
| PL (1) | PL329219A1 (de) |
| PT (1) | PT900078E (de) |
| RU (1) | RU2160098C2 (de) |
| SK (1) | SK133398A3 (de) |
| WO (1) | WO1997037648A1 (de) |
| ZA (1) | ZA972875B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2178B1 (en) | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of emphysema using rar selective retinoid antagonists |
| AU1760201A (en) * | 1999-11-12 | 2001-06-06 | Fred Hutchinson Cancer Research Center | Methods for treatment of human huntington's disease and methods of screening foractive agents |
| TWI306450B (en) * | 2001-12-13 | 2009-02-21 | Wyeth Corp | Substituted phenyl naphthalenes as estrogenic agents |
| UA77526C2 (en) * | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
| CN1777425A (zh) * | 2003-03-28 | 2006-05-24 | 阿卡蒂亚药品公司 | 用于疼痛控制的毒蕈碱性m1受体激动剂 |
| CN111773213B (zh) | 2010-09-01 | 2023-02-24 | 托马斯杰弗逊大学 | 用于肌肉修复和再生的组合物和方法 |
| KR101981930B1 (ko) | 2017-08-10 | 2019-05-27 | 주식회사 에니텍시스 | 랜딩 장치 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU85849A1 (fr) * | 1985-04-11 | 1986-11-05 | Cird | Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques |
| US5455248A (en) * | 1993-09-14 | 1995-10-03 | Sterling Winthrop Inc. | Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof |
| RU2056852C1 (ru) * | 1994-03-18 | 1996-03-27 | Иван Николаевич Головистиков | Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний |
-
1996
- 1996-04-05 FR FR9604359A patent/FR2747041B1/fr not_active Expired - Fee Related
-
1997
- 1997-04-02 RU RU98119892/14A patent/RU2160098C2/ru active
- 1997-04-02 PT PT97919465T patent/PT900078E/pt unknown
- 1997-04-02 AT AT97919465T patent/ATE189385T1/de active
- 1997-04-02 WO PCT/FR1997/000590 patent/WO1997037648A1/fr not_active Ceased
- 1997-04-02 KR KR1019980707851A patent/KR20000005179A/ko not_active Ceased
- 1997-04-02 CZ CZ983176A patent/CZ317698A3/cs unknown
- 1997-04-02 ES ES97919465T patent/ES2144857T3/es not_active Expired - Lifetime
- 1997-04-02 CA CA002250755A patent/CA2250755A1/fr not_active Abandoned
- 1997-04-02 CN CN97195284A patent/CN1221341A/zh active Pending
- 1997-04-02 NZ NZ332158A patent/NZ332158A/en unknown
- 1997-04-02 AU AU23927/97A patent/AU717704B2/en not_active Ceased
- 1997-04-02 PL PL97329219A patent/PL329219A1/xx unknown
- 1997-04-02 BR BR9708511A patent/BR9708511A/pt not_active Application Discontinuation
- 1997-04-02 JP JP09535900A patent/JP2000512619A/ja active Pending
- 1997-04-02 SK SK1333-98A patent/SK133398A3/sk unknown
- 1997-04-02 EP EP97919465A patent/EP0900078B1/de not_active Expired - Lifetime
- 1997-04-02 HU HU9902167A patent/HUP9902167A3/hu unknown
- 1997-04-02 US US09/155,598 patent/US6043280A/en not_active Expired - Fee Related
- 1997-04-02 DE DE69701258T patent/DE69701258T2/de not_active Expired - Fee Related
- 1997-04-04 ZA ZA9702875A patent/ZA972875B/xx unknown
-
1998
- 1998-10-05 NO NO984651A patent/NO984651L/no not_active Application Discontinuation
-
2000
- 2000-03-27 GR GR20000400749T patent/GR3033061T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6043280A (en) | 2000-03-28 |
| NZ332158A (en) | 2000-06-23 |
| FR2747041B1 (fr) | 1998-05-22 |
| ZA972875B (en) | 1997-10-31 |
| CA2250755A1 (fr) | 1997-10-16 |
| JP2000512619A (ja) | 2000-09-26 |
| AU2392797A (en) | 1997-10-29 |
| NO984651D0 (no) | 1998-10-05 |
| ES2144857T3 (es) | 2000-06-16 |
| EP0900078A1 (de) | 1999-03-10 |
| CN1221341A (zh) | 1999-06-30 |
| PL329219A1 (en) | 1999-03-15 |
| GR3033061T3 (en) | 2000-08-31 |
| WO1997037648A1 (fr) | 1997-10-16 |
| KR20000005179A (ko) | 2000-01-25 |
| FR2747041A1 (fr) | 1997-10-10 |
| PT900078E (pt) | 2000-07-31 |
| DE69701258D1 (de) | 2000-03-09 |
| NO984651L (no) | 1998-12-03 |
| AU717704B2 (en) | 2000-03-30 |
| EP0900078B1 (de) | 2000-02-02 |
| BR9708511A (pt) | 1999-08-03 |
| RU2160098C2 (ru) | 2000-12-10 |
| SK133398A3 (en) | 1999-12-10 |
| HUP9902167A2 (hu) | 2000-04-28 |
| HUP9902167A3 (en) | 2000-07-28 |
| DE69701258T2 (de) | 2000-12-21 |
| CZ317698A3 (cs) | 1999-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| ATE332702T1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| ATE212223T1 (de) | Verwendung von sertraline zur herstellung eines arzneimittels zur behandlung von obsessiv- kompulsiven erkrankungen | |
| ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| PL313716A1 (en) | Tetrachloropyridino-(or 4-hydroxypiperidino) alkyloazoles exhibiting activity in respect to sigma and/or 5ht1a receptor | |
| DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
| DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
| DE69820480D1 (de) | Verwendung von wenigsten einem fukan zur herstellung eines arzneimittels für die behandlung pariodontaler erkrankungen | |
| DE69711078D1 (de) | Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz | |
| DE69535131D1 (de) | Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems | |
| DE69701258D1 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| ATE190839T1 (de) | Verwendung von prodelphidinen zur behandlung von arthrose | |
| DE69626916D1 (de) | Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten | |
| NZ320522A (en) | Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds | |
| ATE234613T1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
| DE69620394D1 (de) | Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht | |
| ATE312611T1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
| ATE168697T1 (de) | Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen | |
| ATE232098T1 (de) | Verwendung von efaroxan zur herstellung eines arzneimittels zur behandlung von huntington krankheit | |
| DE69715227D1 (de) | Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit | |
| ATE94558T1 (de) | Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems. |